On-demand education
E-course: Hot topics in renal cell carcinoma (RCC)
ERUS24 special: Mr. Challacombe and Dr. Bertolo discuss robotic resection of RCC recurrence
Recording: Partial nephrectomy: What’s new with the available approaches?
ASCO2024 special: Circulating kidney injury molecule-1 biomarker analysis in IMmotion010
Special series on RCC: Beyond first-line treatment strategies for mRCC with Dr. Mari and Dr. Ciccarese
Special series on RCC: First-line treatment strategies for mRCC with Dr. Mari and Dr. Marandino
Role of cytoreductive nephrectomy for mRCC with Assist. Prof. Mari and Prof. Badani
ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptide
ASCO GU24 special: Prof. Nizar Tannir shares CheckMate 214 results
ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914
UROONCO RCC take home message for 2023
Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg
Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatment
Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patients
Special series: 3D models for kidney cancer with caval thrombous